| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/02/2009 | WO2009015112A3 Metal complexes incorporated within biodegradable nanoparticles and their use |
| 04/02/2009 | WO2009013356A3 Anti-hiv tablet formulations comprising darunavir |
| 04/02/2009 | WO2009011941A3 Monoclonal antibodies against dengue and other viruses with deletion in fc region |
| 04/02/2009 | WO2008124647A3 Immunogenic compositions comprising mycobacterium tuberculosis polypeptides and fusions thereof |
| 04/02/2009 | WO2008092928A4 NOVEL ß-LACTAM ANTIBIOTICS, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF |
| 04/02/2009 | US20090088443 Novel crystalline forms of conazoles and methods of making and using the same |
| 04/02/2009 | US20090088423 Methods and compositions for treating bacterial infections and diseases associated therewith |
| 04/02/2009 | US20090088397 Inhibitors of secretion of hepatitis b virus antigens for treatment of a chronic hepatitis virus |
| 04/02/2009 | US20090088390 Polypeptide |
| 04/02/2009 | US20090088381 Compositions containing anti-hiv peptides and methods for use |
| 04/02/2009 | US20090088378 Long lasting inhibitors of viral infection |
| 04/02/2009 | US20090088372 Novel Bioconjugates As Therapeutic Agent and Synthesis Thereof |
| 04/02/2009 | US20090088365 Biosynthetic Polypeptide Fusion Inhibitors |
| 04/02/2009 | US20090087502 Non-toxic Antimicrobial Composition |
| 04/02/2009 | US20090087482 Temperature-Sensitive Liposomal Formulation |
| 04/02/2009 | US20090087480 Pharmaceutical composition and method using antifungal agent in combination |
| 04/02/2009 | US20090087453 Virosome particles comprising antigens from influenza virus and hepatitis b virus |
| 04/02/2009 | US20090087438 Anti-tsg101 antibodies and their uses for treatment of viral infections |
| 04/02/2009 | US20090087432 TREATING PROSTATE CANCER WITH ANTI-ErbB2 ANTIBODIES |
| 04/02/2009 | US20090087409 Viral Polymerase Inhibitors |
| 04/02/2009 | US20090087403 Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway |
| 04/02/2009 | US20090087389 Dehydroepiandrosterone sulfate dihydrate inhalation compositions and methods |
| 04/02/2009 | DE112007001091T5 Pharmazeutische Formulierung in Form einer Salbe für die Behandlung von Tinea der Füße und Hände und Zubereitungsverfahren davon Pharmaceutical formulation in the form of an ointment for the treatment of tinea of the feet and hands, and preparation method thereof |
| 04/02/2009 | CA2790774A1 Compositions comprising quinolone and methods for treating of controlling infections |
| 04/02/2009 | CA2704134A1 Monoclonal antibodies to respiratory syncytial virus and uses thereof |
| 04/02/2009 | CA2700892A1 Reagents for inducing an immune response |
| 04/02/2009 | CA2700841A1 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
| 04/02/2009 | CA2700227A1 Valomaciclovir polymorphs |
| 04/02/2009 | CA2699244A1 Use of the peptide gly-arg-gly-asp-asn-pro as a therapeutic agent |
| 04/02/2009 | CA2699241A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699177A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699170A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699154A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699153A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699101A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699100A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699077A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699073A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699069A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699068A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699065A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699055A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699054A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699052A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699049A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2699039A1 Use of bpp-b as a therapeutic agent |
| 04/02/2009 | CA2699035A1 Use of insulin c-peptide, alone or in combination with glp-1, as a therapeutic agent |
| 04/02/2009 | CA2699000A1 Use of the peptide his-ser-leu-gly-lys-trp-leu-gly-his-pro-asp-lys-phe alone or in combination with the peptide gly-arg-gly-asp-asn-pro-oh as a therapeutic agent |
| 04/02/2009 | CA2698775A1 Big gastrin i as a therapeutic agent |
| 04/02/2009 | CA2698772A1 Proadrenomedullin alone or in combination with big gastrin i as a therapeutic agent |
| 04/02/2009 | CA2698768A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2698764A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2698762A1 Use of the peptide pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys as a therapeutic agent |
| 04/02/2009 | CA2698751A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2698673A1 Use of a peptide as a therapeutic agent |
| 04/02/2009 | CA2698672A1 Use of a peptide as a therapeutic agent |
| 04/01/2009 | EP2042606A1 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic use |
| 04/01/2009 | EP2042596A1 Polypeptides involved in immune response |
| 04/01/2009 | EP2042512A2 Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof |
| 04/01/2009 | EP2042510A2 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleid acid (siNA) |
| 04/01/2009 | EP2042509A1 Modulators of the function of FAS receptors and other proteins |
| 04/01/2009 | EP2042503A1 Compound having acidic group which may be protected, and use thereof |
| 04/01/2009 | EP2042502A1 Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor |
| 04/01/2009 | EP2042196A2 Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF) |
| 04/01/2009 | EP2042188A1 Pharmaceutical composition for treating or preventing hcv infection |
| 04/01/2009 | EP2041178A2 Single-chain multivalent binding proteins with effector function |
| 04/01/2009 | EP2041160A2 Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy |
| 04/01/2009 | EP2041159A1 Macrocyclic compounds as antiviral agents |
| 04/01/2009 | EP2041152A1 D-glucopyranose 1-[3,5-bis(1,1-dimethylethyl)-4-hydroxybenzoate] compound and its derivatives, preparation thereof and uses thereof |
| 04/01/2009 | EP2041145A1 Azatricyclic compounds and their use |
| 04/01/2009 | EP2041135A1 8-oxoadenine derivatives acting as modulators of tlr7 |
| 04/01/2009 | EP2041067A2 Cxer4 antagonists including diazine and triazine structures for the treatment of medical disorders |
| 04/01/2009 | EP2040730A2 Modulation of nkg2d |
| 04/01/2009 | EP2040727A2 Isolated extract of walnuts, process for its obtention and its use |
| 04/01/2009 | EP2040724A2 Biotherapeutic compositions comprising probiotic escherichia coli and uses thereof |
| 04/01/2009 | EP2040716A1 Cellulose sulfate for the treatment of rhinovirus infection |
| 04/01/2009 | EP2040692A2 Medical use of n-phenylpropenoyl-amino acid derivatives and related compounds |
| 04/01/2009 | EP2040554A1 Reduction of antibiotic resistance in bacteria |
| 04/01/2009 | EP1835916B1 Compounds useful in the treatment of hiv |
| 04/01/2009 | EP1768987B1 (r/s) rifamycin derivatives, their preparation and pharmaceutical compositions |
| 04/01/2009 | EP1549341B1 Tissue factor targeted antibodies as anticoagulants |
| 04/01/2009 | EP1532248B1 Modified small interfering rna molecules and methods of use |
| 04/01/2009 | EP1465640B8 Use of polysaccharide derivatives as anti-infective substances |
| 04/01/2009 | EP1446425B1 Treatment of micro-organism infection |
| 04/01/2009 | EP1349873B1 Modulation of il-2- and il-15-mediated t cell responses |
| 04/01/2009 | CN101400790A Peptide for inhibition of influenza infection, inhibitor of influenza infection, liposome, and prophylactic/therapeutic agent for influenza |
| 04/01/2009 | CN101400785A Method for production of T cell population |
| 04/01/2009 | CN101400693A Peptides of regulatory or accessory proteins of HIV, compositions and the utilization thereof |
| 04/01/2009 | CN101400684A Thiazole compound |
| 04/01/2009 | CN101400674A Antibiotic compounds |
| 04/01/2009 | CN101400670A Novel pyridine derivative having anti-helicobacter pylori activity |
| 04/01/2009 | CN101400365A Use of TFPI to treat severe bacterial infections |
| 04/01/2009 | CN101400352A Compositions and methods for the treatment and prevention of disease |
| 04/01/2009 | CN101400351A Medicament formulations comprising fluoroquinolones |
| 04/01/2009 | CN101397574A Flavivirus NS1 subunit vaccine |
| 04/01/2009 | CN101397572A Method for rescuing influenza virus and bidirectional transcription vector special therefor |
| 04/01/2009 | CN101397336A Antigenic Neisserial peptides |
| 04/01/2009 | CN101397335A Particles of HCV envelope proteins: use for vaccination |
| 04/01/2009 | CN101397334A Anti-human cytomegalovirus gBn1 antibody, preparation method and special antigen |
| 04/01/2009 | CN101397333A De-hydroxyl vancomycin, preparation method thereof, medicament composition and use thereof |